Kimberly E Smith, MD
Dermatology · Tampa, FLNPI 1518072693
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (55.5%), food and beverage and education — rather than concentrated in one kind of arrangement. UCB Biosciences Inc. accounts for 66.5% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2019 at $2,288 and has fallen 99.0% since, to $22 in 2025. That places this record below the midpoint for dermatology clinicians in FL, where the typical reported total is $2,563.
Across 37 payments — averaging $69.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB Biosciences Inc.$2K
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$154
- Sun Pharmaceutical Industries Inc.$99
- Lilly USA, LLC$98
- Genentech USA, Inc.$83
- Galderma Laboratories, L.p.$79
- plus $352 from 11 others
Across 76 payments — averaging $4447.76 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GSK$161K
- UCB SA$159K
- Pfizer$18K
What the payments were for
- Travel & lodging$1,43355%
- Food & beverage$1,05141%
- Education$994%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB Biosciences Inc. | 8 | $1,718 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 6 | $154 |
| Sun Pharmaceutical Industries Inc. | 1 | $99 |
| Lilly USA, LLC | 1 | $98 |
| Genentech USA, Inc. | 5 | $83 |
| Galderma Laboratories, L.p. | 2 | $79 |
| Bristol Myers Squibb | 1 | $65 |
| VYNE Pharmaceuticals Inc. | 2 | $50 |
| Regeneron | 1 | $45 |
| AbbVie(2 entities) | 2 | $41 |
| GSK | 2 | $37 |
| Sandoz | 1 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Cipher Pharmaceuticals US LLC | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
| Journey Medical Corporation | 1 | $16 |
| Almirall LLC | 1 | $13 |
How this compares
$2,583 in reported general payments places this provider in the 50th percentile of 1,147 dermatology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluocinonide | 53 | $2,533 |
| Betamethasone Dipropionate | 48 | $1,636 |
| Ketoconazole | 66 | $1,341 |
| Imiquimod | 26 | $921 |
| Metronidazole | 16 | $895 |
| Clindamycin Phosphate | 22 | $582 |
| Triamcinolone Acetonide | 83 | $582 |
| Minocycline Hcl | 24 | $577 |
| Permethrin | 15 | $536 |
| Minoxidil | 62 | $449 |
| Ciclopirox | 13 | $434 |
| Mupirocin | 49 | $346 |
| Hydrocortisone Valerate | 15 | $332 |
| Cephalexin | 40 | $280 |
| ValacyclovirValacyclovir Hcl | 14 | $248 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Tampa
- Seth FormanTampa$407K
- Asha ShahTampa$332K
- Nishit PatelTampa$111K
- Francisco KerdelMiami$2.1M
- Brad GlickMargate$2M
- Robert KirsnerMiami$1.4M
- John MinniStuart$1.4M
- Gil YosipovitchMiami$1M
- Shino Bay AguileraFt Lauderdale$1M
- Robert SnyderPembroke Pines$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.